Mammary carcinoma: Comparative oncology between small animals and humans—New therapeutic tools - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Reproduction in Domestic Animals Année : 2023

Mammary carcinoma: Comparative oncology between small animals and humans—New therapeutic tools

Résumé

Abstract The poor outcomes associated with mammary carcinomas (MCs) in dogs and cats in terms of locoregional recurrence, distant metastasis and survival, highlight the need for better management of mammary cancers in small animals. By contrast, the outcomes of women with breast cancer (BC) have dramatically improved during the last 10 years, notably thanks to new therapeutic strategies. The aim of this article was to imagine what could be the future of therapy for dogs and cats with MCs if it became inspired from current practices in human BC. This article focuses on the importance of taking into account cancer stage and cancer subtypes in therapeutic plans, on locoregional treatments (surgery, radiation therapy), new developments in endocrine therapy, chemotherapy, PARP inhibitors and immunotherapy. Ideally, multimodal treatment regimens would be chosen according to cancer stage and cancer subtypes, and according to predictive factors that are still to be defined.

Dates et versions

inserm-04441552 , version 1 (06-02-2024)

Identifiants

Citer

Jean‐sébastien Frénel, Frédérique Nguyen. Mammary carcinoma: Comparative oncology between small animals and humans—New therapeutic tools. Reproduction in Domestic Animals, 2023, 58 (S2), pp.102-108. ⟨10.1111/rda.14408⟩. ⟨inserm-04441552⟩
6 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More